Related Experiment Video
Updated: Oct 4, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Diagnostic approach in adult-onset neurometabolic diseases
Gorka Fernández-Eulate1,2, Christophe Carreau3, Jean-François Benoist4
1Neuro-Metabolism Unit, Reference Center for Lysosomal Diseases, Neurology Department, Pitié-Salpêtrière University Hospital, APHP, Paris, France.
Insights
Neurometabolic diseases, though rare, are treatable genetic disorders often missed in adults. Early diagnosis is crucial for effective management and improved patient outcomes.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Neurometabolic diseases are numerous, heterogeneous genetic disorders.
- Adult-onset forms present unique challenges, mimicking common neurological conditions.
- Many neurometabolic diseases are treatable, yet face diagnostic delays due to complexity.
Purpose of the Study:
- To review treatable neurometabolic diseases with adult neurological onset.
- To classify these diseases by clinical manifestations.
- To propose a simplified diagnostic approach for neurologists.
Main Methods:
- Systematic review of case reports and series of patients with neurological onset after age 10.
- Focus on 36 treatable neurometabolic diseases.
- Classification based on clinical manifestations and discussion of diagnostic biochemical tests and therapeutics.
Main Results:
- Identified and classified treatable neurometabolic diseases presenting in adults.
- Highlighted the diagnostic delay and underdiagnosis issues.
- Emphasized the impact of timely diagnosis on patient stabilization and familial screening.
Conclusions:
- A simplified diagnostic approach can aid neurologists in suspecting and managing neurometabolic diseases.
- Next-generation sequencing, coupled with deep phenotyping, is vital for improving diagnostic yield.
- Early and accurate diagnosis of treatable neurometabolic disorders significantly benefits patients.
Abstract:
Neurometabolic diseases are a group of individually rare but numerous and heterogeneous genetic diseases best known to paediatricians. The more recently reported adult forms may present with phenotypes strikingly different from paediatric ones and may mimic other more common neurological disorders in adults. Furthermore, unlike most neurogenetic diseases, many neurometabolic diseases are treatable, with both conservative and more recent innovative therapeutics. However, the phenotypical complexity of this group of diseases and the growing number of specialised biochemical tools account for a significant diagnostic delay and underdiagnosis. We reviewed all series and case reports of patients with a confirmed neurometabolic disease and a neurological onset after the age of 10 years, with a focus on the 36 treatable ones, and classified these diseases according to their most relevant clinical manifestations. The biochemical diagnostic approach of neurometabolic diseases lays on the use of numerous tests studying a set of metabolites, an enzymatic activity or the function of a given pathway; and therapeutic options aim to restore the enzyme activity or metabolic function, limit the accumulation of toxic substrates or substitute the deficient products. A quick diagnosis of a treatable neurometabolic disease can have a major impact on patients, leading to the stabilisation of the disease and cease of repeated diagnostic investigations, and allowing for familial screening. For the aforementioned, in addition to an exhaustive and clinically meaningful review of these diseases, we propose a simplified diagnostic approach for the neurologist with the aim to help determine when to suspect a neurometabolic disease and how to proceed in a rational manner. We also discuss the place of next-generation sequencing technologies in the diagnostic process, for which deep phenotyping of patients (both clinical and biochemical) is necessary for improving their diagnostic yield.
Related Concept Videos
Inborn Errors of Metabolism
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

